IT1317369B1 - Farmaco colinergico (in particolare colina alfoscerato) combinato confarmaco anticolinesterasico. - Google Patents

Farmaco colinergico (in particolare colina alfoscerato) combinato confarmaco anticolinesterasico.

Info

Publication number
IT1317369B1
IT1317369B1 ITPD20000238A IT1317369B1 IT 1317369 B1 IT1317369 B1 IT 1317369B1 IT PD20000238 A ITPD20000238 A IT PD20000238A IT 1317369 B1 IT1317369 B1 IT 1317369B1
Authority
IT
Italy
Prior art keywords
rivastigmine
drugs
drug
alzheimer
disease
Prior art date
Application number
Other languages
English (en)
Inventor
Mariano Trognoni
Original Assignee
M D M S R L Ora M D M S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M D M S R L Ora M D M S P A filed Critical M D M S R L Ora M D M S P A
Priority to IT2000PD000238 priority Critical patent/IT1317369B1/it
Priority to EP01123726A priority patent/EP1203584A1/en
Publication of ITPD20000238A1 publication Critical patent/ITPD20000238A1/it
Application granted granted Critical
Publication of IT1317369B1 publication Critical patent/IT1317369B1/it

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT2000PD000238 2000-10-13 2000-10-13 Farmaco colinergico (in particolare colina alfoscerato) combinato confarmaco anticolinesterasico. IT1317369B1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT2000PD000238 IT1317369B1 (it) 2000-10-13 2000-10-13 Farmaco colinergico (in particolare colina alfoscerato) combinato confarmaco anticolinesterasico.
EP01123726A EP1203584A1 (en) 2000-10-13 2001-10-04 Cholinergic precursor (in particular choline alfoscerate) associated with an acetylcholinesterase inhibitor (such as rivastigmine, donepezil)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000PD000238 IT1317369B1 (it) 2000-10-13 2000-10-13 Farmaco colinergico (in particolare colina alfoscerato) combinato confarmaco anticolinesterasico.

Publications (2)

Publication Number Publication Date
ITPD20000238A1 ITPD20000238A1 (it) 2002-04-13
IT1317369B1 true IT1317369B1 (it) 2003-06-16

Family

ID=11452086

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000PD000238 IT1317369B1 (it) 2000-10-13 2000-10-13 Farmaco colinergico (in particolare colina alfoscerato) combinato confarmaco anticolinesterasico.

Country Status (1)

Country Link
IT (1) IT1317369B1 (it)

Also Published As

Publication number Publication date
ITPD20000238A1 (it) 2002-04-13

Similar Documents

Publication Publication Date Title
Raskin et al. Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension.
HK1028874A1 (en) Methods and compositions for inhibition of angiogenesis
HRP940029B1 (en) Pharmaceutical composition for treating nicotine dependence
WO2001001973A8 (en) Highly selective norepinephrine reuptake inhibitors and methods of using the same
GEP20033090B (en) Derivatives of Acyl-Piperazinil-Pyrimidins, Preparation, Method for Their Preparation and Their Application
CA2351347A1 (en) Dosage formulations for acetylcholinesterase inhibitors
CA2687118A1 (en) Methods of using low-dose doxepin for the improvement of sleep
ES2147788T3 (es) 3,4-diarilcromanos para el tratamiento de la dermatitis.
WO2001051044A3 (en) Substances for use in treating psoriasis
BR0214075A (pt) Dosagem unitária que compreende um análogo de prostaglandina para tratar constipação
EP1203584A1 (en) Cholinergic precursor (in particular choline alfoscerate) associated with an acetylcholinesterase inhibitor (such as rivastigmine, donepezil)
IT1317369B1 (it) Farmaco colinergico (in particolare colina alfoscerato) combinato confarmaco anticolinesterasico.
Borys et al. The effects of fluoxetine in the overdose patient
IL106785A0 (en) Use of nadh and nadph as drugs for treating alzheimer's disease
BG103687A (en) Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative processes and conditions related to the central nervous system
WO2001012214A3 (en) MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PEG-IFN-$g(a)
WO2002007716A3 (en) Method for treating angina
WO2000071520A3 (en) Aryl substituted alkylamines capable of activating nicotinic cholinergic receptors
WO2002005801A3 (en) Compositions containing diacyltartaric salts of (e)-metanicotine
Scott Repeated asystole following PAM in organophosphate self-poisoning
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
WO1999052518A3 (en) New treatments for nervous disorders
AU1651697A (en) Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders
KR910007528A (ko) 벤조디아제핀 및 페닐피릴케톤 유도체의 용도
EP0555302A1 (en) Method of treating demyelinating disease